A variation in the apolipoprotein C-III gene is associated with an increased number of circulating VLDL and IDL particles in familial combined hyperlipidemia

Journal of Lipid Research

Volumn 38, Issue 6, 1997, Pages 1061-1069

  Ribalta, Josep ^a   La Ville, Agnes E ^a   Vallvé, Joan C ^a   Humphries, Steve ^b   Turner, Peter R ^a   Masana, Lluis ^a  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

A I C III A IV gene cluster; CAD; Genetic marker; Genotype status interaction; Metabolic syndrome; Predisposition; Remnant particles

Indexed keywords

APOLIPOPROTEIN C; INTERMEDIATE DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; DRUG BLOOD LEVEL; FAMILIAL DISEASE; FEMALE; GENE CLUSTER; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERLIPIDEMIA; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MULTIGENE FAMILY; PRIORITY JOURNAL;

EID: 0030978794     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Rose, H. G., P. Kranz, M. Weinstock, J. Juliano, and J. I. Haft. 1973. Inheritance of combined hyperlipoproteinemia: evidence for a new lipoprotein phenotype. Am. J. Med. 54: 148-160.
2. Goldstein, J. L., H. G. Schrott, W. R. Hazzard, E. L. Bierman, and A. G. Motulsky. 1973. Hyperlipidaemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidaemia. J. Clin. Invest. 52: 1544-1568.
3. Kwiterovich, P. O., Jr. 1993. Genetics and molecular biology of familial combined hyperlipidemia. Curr. Opin. Lipidol. 4: 133-143.
4. Castro Cabezas, M., T. W. A. de Bruin, and D. W. Erkelens. 1992. Familial Combined Hyperlipidemia: 1973-1991. Neth. J. Med, 40: 83-95.
5. Grundy, S. M., A. Chait, and J. D. Brunzell. 1987. Familial combined hyperlipidemia workshop. Arteriosclerosis. 7: 203-207.
6. Cortner, J. A., P. M. Coates, and P. R. Gallagher. 1990. Prevalence and expression of familial combined hyperlipidemia in childhood. J. Pediatr. 116: 514-519.
7. Brunzell, J. D., J. J. Albers, A. Chait, S. M. Grundy, E. Groszek, and G. B. Mc Donald. 1983. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J. Lipid Res. 24: 147-155.
8. Nikkilä, E. A., and A. Aro. 1973. Family study of serum lipids and lipoproteins in coronary heart disease. Lancet. 1: 954-959.
9. Chait, A., J. J. Albers, and J. D. Brunzell. 1980. Very low density lipoprotein overproduction in genetic forms of hypertriglyceridemia. Eur. J. Clin. Invest. 10: 17-22.
10. Cortner, J. A., P. M. Coates, M. J. Bennett, D. R. Cryer, and N. A. Le. 1991. Familial combined hyperlipidemia: use of stable isotopes to demonstrate overproduction of very-low-density lipoprotein apolipoprotein B by the liver. J. Inherited Dis. 14: 915-922.
11. Janus, E. D., A. M. Nicoll, P. R. Turner, P. Magill, and B. Lewis. 1980. Kinetic bases of the primary hyperlipidemias: studies of apolipoprotein B turnover in genetically defined subjects. Eur. J. Clin. Invest. 10: 161-172.
12. Venkatesan, S., P. Cullen, P. Pacy, D. Halliday, and J. Scott. 1993. Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Arterioscler. Thromb. 13: 1110-1118.
13. Raugh, G., H. Schuster, B. Müller, S. Schewe, C. Keller, G. Wolfram, and N. Zöllner. 1990. Genetic evidence from 7 families that the apoB gene is not involved in familial combined hyperlipidemia. Atherosclerosis. 83: 81-87.
14. Austin, M. A., E. Wijsman, S. W. Guo, R. M. Krauss, J. D. Brunzell, and S. Deeb. 1991. Lack of evidence for linkage between low-density lipoprotein subclass phenotypes and the apolipoprotein B locus in familial combined hyperlipidemia. Genet. Epidemiol. 8: 287-297.
15. Ginsberg, H. N., N. A. Le, I. J. Goldberg, J. C. Gibson, A. Rubinstein, P. Wang-Iverson, R. Norum, and V. W. Brown. 1986. Apolipoprotein B metabolism in subjects with deficiency of apolipoprotein C-III and A-I: evidence that apolipoprotein C-III inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J. Clin. Invest. 8: 1287-1295.
16. Brown, W. V., and M. L. Baginsky. 1972. Inhibition of lipoprotein lipase by an apolipoprotein of human very low density lipoprotein. Biochem. Biophys. Res. Commun. 46: 375-382.
17. Auwerx, J., P. Leroy, and K. Schoonjans. 1992. Lipoprotein lipase: recent contributions from molecular biology. Crit. Rev. Cl. Lab. Sci. 3,4: 243-268.
18. Williams, K. J., K. A. Petrie, R. W. Brocia, and T. L. Swenson. 1991. Lipoprotein lipase regulates net secretory output of apolipoprotein B in vitro: a possible pathophysiologic explanation for familial combined hyperlipidemia. J. Clin. Invest. 88: 1300-1306.
19. De Silva, H. V., S. J. Lauer, J. Wang, W. S. Simonet, K. H. Weisgraber, R. W. Mahley, and J. M. Taylor. 1994. Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E. J. Biol. Chem. 269: 2324-2335.
20. Aalto-Setälä, K., E. A. Fisher, X. Chen, T. Chajek-Shaul, T. Hayek, R. Zechner, A. Walsh, R. Ramakrishnan, H. N. Ginsberg, and J. L. Breslow. 1992. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) C-III transgenic mice. J. Clin. Invest. 90: 1889-1900.
21. Ito, Y., N. Azrolan, A. O'Connell, A. Walsh, and J. L. Breslow. 1990. Hypertriglyceridemia as a result of human apoC-III gene expression in transgenic mice. Science. 249: 790-793.
22. Castro Cabezas, M., T. W. A. de Bruin, H. Jansen, A. W. Kock, W. Kortlandt, and D. W. Erkelens. 1993. Impaired chylomicron remnant clearance in Familial Combined Hyperlipidemia. Arterioscler. Thromb. 13: 804-814.
23. Wiseman, S., J. T. Powell, N. Barber, S. E. Humphries, and R. M. Greenhalgh. 1991. Influence of apolipoproteins on the anatomical distribution of arterial disease. Atherosclerosis. 89: 231-237.
24. Blankenhorn, D. H., P. Alaupovic, E. Wickmaam, H. P. Chin, and S. P. Azen. 1990. Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Circulation. 81: 470-476.
25. Kessling, A. M., B. Horsthemke, and S. E. Humphries. 1985. A study of DNA polymorphisms around the human apolipoprotein A-I gene in hyperlipidemic and normal individuals. Clin. Genet. 28: 296-306.
26. Wojciechowski, A. P., M. Farrall, P. Cullen, T. M. E. Wilson, J. D. Bayliss, B. Farren, B. A. Griffin, M. J. Caslake, C. J. Packard, J. Shepherd, R. Thakker, and J. Scott. 1991. Familial combined hyperlipidemia linked to the apolipoprotein AI-CII-AIV gene cluster on chromosome 11q23- q24. Nature. 249: 161-164.
27. Xu, C. F., P. Talmud, H. Schuster, R. Houlston, G. Miller, and S. Humphries. 1994. Association between genetic variation at the apoAI-CIII-AIV gene cluster and familial combined hyperlipidemia. Clin. Genet. 46: 385-397.
28. Dallinga-Thie, G. M., X-D. Bu, M. v L-S. Trip, J. I. Rotter, A. J. Lusis, and T. W. A. de Bruin. 1996. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III. J. Lipid Res. 37: 136-147.
29. Schumaker, V. R., and D. L. Puppione. 1986. Sequential flotation ultracentrifugation. Methods Enzymol. 128: 155-170.
30. Miller, S. A., D. D. Dykes, and H. F. Polesky. 1988. A simple salting out method procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215.
31. Xu, C. F., P. Talmud, and S. E. Humphries. 1994. Three new polymorphisms of the apoAI-CIII-ATV gene cluster. Mol. Cell. Probes. 8: 331-332.
32. Lopez, D., I. Plaza, M. T. Muñoz, R. Madero, J. Otero, I. Hidalgo, J. Baeza, M. J. Ceñal, A. Cobaleda, I. Parra, C. Ruiz, and J. Dominguez. 1989. Estudio de Fuenlabrada: Lipidos y lipoproteínas en niños y adolescentes. An. Esp. Pediatr. 31: 342-349.
33. Castro Cabezas, M., T. W. A., de Bruin, H. W. de Valk, C. C. Shoulders, H. Jansen, and D. W. Erkelens. 1993. Impaired fatty acid metabolism in familial combined hyperlipidemia. J. Clin. Invest. 92: 160-168.
34. Hayden, M. R., H. Kirk, C. Clark, J. Frohlich, S. Rabkin, R. McLeod, and J. Hewitt. 1987. DNA polymorphisms in and around the apoAI-CIII-AIV genes and genetic hyperlipidemias. Am. J. Hum. Genet. 40: 421-430.
35. Dammerman, M., L. A. Sandkuijl, J. L. Halaas, and J. L. Breslow. 1993. An apolipoprotein C-III haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated polymorphisms. Proc. Natl. Acad. Sci. USA. 90: 4562-4566.